Status:
COMPLETED
Long-term outcomeS of cavotrIcuspid isthMus-dePendent fLuttEr Ablation: Single vs Double Catheter Procedure
Lead Sponsor:
Centro Medico Teknon
Conditions:
Atrial Flutter
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Catheter ablation is recommended as first-line therapy for most patients with typical atrial flutter. The most common approach is to create an ablation line across the cavotricuspid isthmus (CTI). Tra...
Detailed Description
Typical atrial flutter is a reentrant rhythm in the right atrium that is constrained anteriorly by the tricuspid annulus and posteriorly by the crista terminalis and eustachian ridge. Catheter ablatio...
Eligibility Criteria
Inclusion
- Patients admitted at any of the centers to perform a CTI ablation.
- Signed informed consent
Exclusion
- Age \< 18 years.
- Pregnancy.
- Impossibility to perform CTI ablation.
- Impossibility to measure PRI (complete atrioventricular block).
- Ablation of other cardiac arrhythmias during the same procedure.
- Medical, geographical and social factors that make study participation impractical, and inability to give written informed consent. Patient's refusal to participate in the study.
Key Trial Info
Start Date :
July 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
253 Patients enrolled
Trial Details
Trial ID
NCT04472936
Start Date
July 16 2020
End Date
November 30 2022
Last Update
August 30 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Medico Teknon
Barcelona, Spain, 08022
2
Puerta del Mar University Hospital
Cadiz, Spain
3
Virgen del Rocio University Hospital
Seville, Spain